Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Scheithauer

Showing results (831-840 of 856) with videos related to

Pageof 86
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
The Lancet. Neurology|December 1, 2009
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive studyDaniel H Lachance, Vanda A Lennon, Sean J Pittock, et al.
Brain : a Journal of Neurology|June 7, 2008
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosisC F Lucchinetti, R H Gavrilova, I Metz, et al.
Genes, Chromosomes & Cancer|August 5, 2000
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markersJ S Smith, I Tachibana, H K Lee, et al.
Cancer|July 24, 2001
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade gliomaJ C Buckner, P J Schomberg, W L McGinnis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trialW Scheithauer, J McKendrick, S Begbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Pituitary|July 12, 2011
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutationLuis V Syro, Jamie L Sundsbak, Bernd W Scheithauer, et al.
Cancer|August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionA Perry, R B Jenkins, J R O'Fallon, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2001
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini, B W Scheithauer, A L Weaver, et al.
Pageof 86

Showing results (831-840 of 856) with videos related to

Sort By:
Pageof 86
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
The Lancet. Neurology|December 1, 2009
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive studyDaniel H Lachance, Vanda A Lennon, Sean J Pittock, et al.
Brain : a Journal of Neurology|June 7, 2008
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosisC F Lucchinetti, R H Gavrilova, I Metz, et al.
Genes, Chromosomes & Cancer|August 5, 2000
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markersJ S Smith, I Tachibana, H K Lee, et al.
Cancer|July 24, 2001
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade gliomaJ C Buckner, P J Schomberg, W L McGinnis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trialW Scheithauer, J McKendrick, S Begbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Pituitary|July 12, 2011
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutationLuis V Syro, Jamie L Sundsbak, Bernd W Scheithauer, et al.
Cancer|August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionA Perry, R B Jenkins, J R O'Fallon, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2001
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini, B W Scheithauer, A L Weaver, et al.
Pageof 86